The influence of hypoxia and hyperoxia on the kinetics of propofol emulsion

Canadian Journal of Anaesthesia

Volumn 46, Issue 12, 1999, Pages 1150-1155

  Yamamoto, Ken ^a   Tsubokawa, Tsunehisa ^a   Yagi, Toshihiro ^a   Ishizuka, Shuichi ^a   Ohmura, Shigeo ^a   Kobayashi, Tsutomu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLURANE; KETONE; PROPOFOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENERGY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; EMULSION; HYPEROXIA; HYPOXIA; INFUSION; LIVER BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033373144     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03015525     Document Type: Article

References (28)

1. Gepts E, Camu F, Cockshott ID, Douglas EJ. Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66: 1256-63.
2. Canivet JL, Gustad K, Leclercq P, Damas P, Lamy M. Massive ketonuria during sedation with propofol in a 12 year old girl with severe head trauma. Acta Anaesthesiol Belg 1994; 45: 19-22.
3. Parke TJ, Stevens JE, Rice ASC, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-6.
4. Strickland RA, Murray MJ. Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship? Crit Care Med 1995; 23: 405-9.
5. Pepperman ML, Macrae D. A comparison of propofol and other sedative use in paediatric intensive care in the United Kingdom. Paediatr Anaesth 1997; 7: 143-53.
6. Hakkinen JP, Miller MW, Smith AH, Knight DR. Measurement of organ blood flow with coloured microspheres in the rat. Cardiovasc Res 1995; 29: 74-9.
7. Plummer GF. Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 421: 171-6.
8. Ukikusa M, Ida T, Ozawa K, Tobe T. The influence of hypoxia and hemorrhage upon adenylate energy charge and bile flow. Surg Gynecol Obstet 1979; 149: 346-52.
9. Tanaka J, Ozawa K, Tobe T. Significance of blood ketone body ratio as an indicator of hepatic cellular energy status in jaundiced rabbits. Gastroenterology 1979; 76: 691-6.
10. Asonuma K, Takaya S, Selby R, et al. The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation. Transplantation 1991; 51: 164-71.
11. Adam HK, Glen JB, Hoyle PA. Pharmacokinetics in laboratory animals of ICI 35 868, a new i.v. anaesthetic agent. Br J Anaesth 1980; 52: 743-6.
12. Cockshott ID, Douglas EJ, Plummer GF, Simons PJ. The pharmacokinetics of propofol in laboratory animals. Xenobiotica 1992; 22: 369-75.
13. Adachi H, Strauss HW, Ochi H, Wagner HN Jr. The effect of hypoxia on the regional distribution of cardiac output in the dog. Circ Res 1976; 39: 314-9.
14. Marshall JM, Metcalfe JD. Effects of systemic hypoxia on the distribution of cardiac output in the rat. J Physiol 1990; 426: 335-53.
15. Ross WT Jr, Daggy BP. Hepatic blood flow in phenobarbital-pretreated rats during halothane anesthesia and hypoxia. Anesth Analg 1981; 60: 306-9.
16. Pagel PS, Warltier DC. Negative inotropic effects of propofol as evaluated by the regional preload recruitable stroke work relationship in chronically instrumented dogs. Anesthesiology 1993; 78: 100-8.
17. Brüssel T, Theissen JL, Vigfusson G, Lunkenheimer PP, Van Aken H, Lawin P. Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol. Anesth Analg 1989; 69: 35-40.
18. Mather LE, Selby DG, Runciman WB, McLean CF. Propofol: assay and regional mass balance in the sheep. Xenobiotica 1989; 19: 1337-47.
19. Lange H, Stephan H, Rieke H, Kellermann M, Sonntag H, Bircher J. Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery. Br J Anaesth 1990; 64: 563-70.
20. Kanto J, Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacokinet 1989; 17: 308-26.
21. Veroli P, O'Kelly B, Bertrand F, Trouvin JH, Farinotti R, Ecoffey C. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br J Anaesth 1992; 68: 183-6.
22. Audibert G, Saunier CG, Du Souich P. In vivo and in vitro effect of cimetidine, inflammation, and hypoxia on propofol kinetics. Drug Metab Dispos 1993; 21: 7-12.
23. Le Guellec C, Lacarelle B, Villard P-H, Point H, Catalin J, Durand A. Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs. Anesth Analg 1995; 81: 855-61.
24. 14C-propofol. Xenobiotica 1988; 18: 429-40.
25. Jordi-Racine AL, Alvarez E, Reichen J. The effect of hypoxia on hepatic cytochromes and heme turnover in rats in vivo. Experientia 1988; 44: 343-5.
26. Wu Y-R, Kauffman FC, Qu W, Ganey P, Thurman RG. Unique role of oxygen in regulation of hepatic monooxygenation and glucuronidation. Mol Pharmacol 1990; 38: 128-33.
27. Martin PH, Murthy BV, Petros AJ. Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care. Br J Anaesth 1997; 79: 276-9.
28. Tsubokawa T, Yamamoto K, Nishimura K, Yagi T, Kobayashi T. Effects of inhaled oxygen concentration on fat metabolism during propofol infusion in rabbits. Br J Anaesth 1998; 81: 761-5.